Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer.
AuthorsWedge, D C
Allwood, J W
Vaughan, A A
Simpson, Kathryn L
Blackhall, Fiona H
Whetton, Anthony D
AffiliationSchool of Chemistry, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
MetadataShow full item record
AbstractIn clinical analyses, the most appropriate biofluid should be analyzed for optimal assay performance. For biological fluids, the most readily accessible is blood, and metabolomic analyses can be performed either on plasma or serum. To determine the optimal agent for analysis, metabolic profiles of matched human serum and plasma were assessed by gas chromatography/time-of-flight mass spectrometry and ultrahigh-performance liquid chromatography mass spectrometry (in positive and negative electrospray ionization modes). Comparison of the two metabolomes, in terms of reproducibility, discriminative ability and coverage, indicated that they offered similar analytical opportunities. An analysis of the variation between 29 small-cell lung cancer (SCLC) patients revealed that the differences between individuals are markedly similar for the two biofluids. However, significant differences between the levels of some specific metabolites were identified, as were differences in the intersubject variability of some metabolite levels. Glycerophosphocholines, erythritol, creatinine, hexadecanoic acid, and glutamine in plasma, but not in serum, were shown to correlate with life expectancy for SCLC patients, indicating the utility of metabolomic analyses in clinical prognosis and the particular utility of plasma in relation to the clinical management of SCLC.
CitationIs serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer. 2011, 83 (17):6689-97 Anal Chem
- Urinary metabolomic study of non-small cell lung carcinoma based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
- Authors: Wu Q, Wang Y, Gu X, Zhou J, Zhang H, Lv W, Chen Z, Yan C
- Issue date: 2014 Jul
- Comparison of serum versus plasma collection in gas chromatography--mass spectrometry-based metabolomics.
- Authors: Dettmer K, Almstetter MF, Appel IJ, Nürnberger N, Schlamberger G, Gronwald W, Meyer HH, Oefner PJ
- Issue date: 2010 Jul
- Differences in metabolite profile between blood plasma and serum.
- Authors: Liu L, Aa J, Wang G, Yan B, Zhang Y, Wang X, Zhao C, Cao B, Shi J, Li M, Zheng T, Zheng Y, Hao G, Zhou F, Sun J, Wu Z
- Issue date: 2010 Nov 15
- Liquid chromatography-mass spectrometry calibration transfer and metabolomics data fusion.
- Authors: Vaughan AA, Dunn WB, Allwood JW, Wedge DC, Blackhall FH, Whetton AD, Dive C, Goodacre R
- Issue date: 2012 Nov 20
- Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry.
- Authors: Chen Y, Ma Z, Li A, Li H, Wang B, Zhong J, Min L, Dai L
- Issue date: 2015 Apr